Expertise:
Peritoneal Mesothelioma
Research
Speciality:
Thoracic Surgery
Gender:
Female
Language:
English

Get to Know Dr. Christine Lau

Dr. Christine Lau was named chief of surgery at the University of Maryland School of Medicine in 2019, taking leadership of one of America’s most acclaimed academic medical centers.

She is the first woman to chair the department of surgery at the University of Maryland School of Medicine since it opened in the 1800s. She also is one of only a few women to lead a major department of surgery in the United States today, according to the school.

Lau served previously at the University of Virginia School of Medicine, division of thoracic and cardiovascular surgery. She played a major role in both the lung cancer and mesothelioma cancer programs there.

She has continued her mesothelioma treatment work at the University of Maryland, performing aggressive surgery for the rare peritoneal mesothelioma cancer.

Specialties of Dr. Christine L. Lau

  • Pleural and lung cancer
  • Research
  • Thoracic surgery

 Dr. Christine L. Lau’s Experience and Medical Education

  • Geisel School of Medicine at Dartmouth (M.D.)
  • Duke University Medical Center (Residency)
  • Washington University School of Medicine (Fellowship)

Awards and Certifications

  • Top Doctor in America, Newsweek
  • Double board certified in general surgery and thoracic surgery

 Testimonials

  • Dr. Mohan Suntha, president of the University of Maryland Medical Center: “Dr. Lau brings a stellar record of clinical and research accomplishments to our already outstanding department of surgery. Her demonstrated commitment to excellence in patient care, as well as to driving innovation and discovery, bode well for the future of the department.”
  • Dr. E. Albert Reece, dean, University of Maryland School of Medicine: “She has been a true pioneer in the field of lung transplantation, and the School of Medicine will continue its upward trajectory resulting from her strong record of academic and clinical leadership.”

Publications of Dr. Christine L. Lau

  • Prasad, N.K. et al. (2020, October). Ex Vivo Lung Perfusion: Current Achievements and Future Directions. Transplantation.
  • Pasrija, C., Shah, A., Kaczorowski, D.J. & Lau, C.L. (2020, July). Cardiac and Pulmonary Transplant Considerations During COVID-19 Pandemic. Innovations.
  • Shah, A. et al. (2020, March). Commentary: Does an expeditious evaluation for high-acuity lung transplant recipients make a difference? Journal of Thoracic and Cardiovascular Therapy.